MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 38 filers reported holding MARRONE BIO INNOVATIONS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $49,002,000 | +47.5% | 23,445,757 | -11.8% | 0.10% | +44.3% |
| Q4 2020 | $33,221,000 | +8.5% | 26,576,683 | +5.9% | 0.07% | -4.1% |
| Q3 2020 | $30,617,000 | +5.6% | 25,095,634 | +1.2% | 0.07% | -2.7% |
| Q2 2020 | $29,001,000 | +45.5% | 24,787,082 | +1.6% | 0.08% | +15.4% |
| Q1 2020 | $19,933,000 | -19.1% | 24,401,392 | 0.0% | 0.06% | +6.6% |
| Q4 2019 | $24,645,000 | -29.3% | 24,401,392 | -1.3% | 0.06% | -32.2% |
| Q3 2019 | $34,848,000 | -6.0% | 24,714,892 | 0.0% | 0.09% | -2.2% |
| Q2 2019 | $37,072,000 | -2.0% | 24,714,892 | 0.0% | 0.09% | -2.1% |
| Q1 2019 | $37,814,000 | +4.1% | 24,714,892 | 0.0% | 0.09% | -8.7% |
| Q4 2018 | $36,331,000 | -19.7% | 24,714,892 | 0.0% | 0.10% | +3.0% |
| Q3 2018 | $45,228,000 | +427.5% | 24,714,892 | +424.2% | 0.10% | +400.0% |
| Q2 2018 | $8,574,000 | -81.9% | 4,714,892 | -80.9% | 0.02% | -81.3% |
| Q1 2018 | $47,321,000 | +812.5% | 24,714,892 | +424.2% | 0.11% | +791.7% |
| Q4 2017 | $5,186,000 | -4.4% | 4,714,892 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $5,423,000 | -10.8% | 4,714,892 | 0.0% | 0.01% | -7.7% |
| Q2 2017 | $6,082,000 | -33.8% | 4,714,892 | 0.0% | 0.01% | -35.0% |
| Q1 2017 | $9,194,000 | -9.1% | 4,714,892 | -0.2% | 0.02% | -9.1% |
| Q4 2016 | $10,114,000 | +23.3% | 4,726,192 | -0.9% | 0.02% | +29.4% |
| Q3 2016 | $8,201,000 | +109.7% | 4,768,092 | 0.0% | 0.02% | +112.5% |
| Q2 2016 | $3,910,000 | -8.9% | 4,768,092 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $4,291,000 | -18.2% | 4,768,092 | 0.0% | 0.01% | -11.1% |
| Q4 2015 | $5,245,000 | -47.9% | 4,768,092 | 0.0% | 0.01% | -47.1% |
| Q3 2015 | $10,061,000 | +6.6% | 4,768,092 | 0.0% | 0.02% | +30.8% |
| Q2 2015 | $9,441,000 | -48.8% | 4,768,092 | 0.0% | 0.01% | -50.0% |
| Q1 2015 | $18,452,000 | +7.2% | 4,768,092 | 0.0% | 0.03% | +8.3% |
| Q4 2014 | $17,213,000 | +35.7% | 4,768,092 | 0.0% | 0.02% | +33.3% |
| Q3 2014 | $12,683,000 | -77.1% | 4,768,092 | +0.2% | 0.02% | -77.8% |
| Q2 2014 | $55,274,000 | +123.3% | 4,756,792 | +168.5% | 0.08% | +113.2% |
| Q1 2014 | $24,754,000 | +35.3% | 1,771,900 | +72.2% | 0.04% | +31.0% |
| Q4 2013 | $18,296,000 | +8.6% | 1,029,000 | +2.9% | 0.03% | -9.4% |
| Q3 2013 | $16,850,000 | – | 1,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 14,303,099 | $15,635,000 | 3.02% |
| ICM ASSET MANAGEMENT INC/WA | 21,500 | $26,000 | 0.14% |
| Fairpointe Capital LLC | 613,900 | $749,000 | 0.12% |
| WADDELL & REED FINANCIAL INC | 25,095,634 | $30,617,000 | 0.07% |
| WEDBUSH SECURITIES INC | 37,129 | $45,000 | 0.00% |
| Financial Advocates Investment Management | 30,925 | $38,000 | 0.00% |
| PRIMECAP MANAGEMENT CO/CA/ | 2,035,300 | $2,483,000 | 0.00% |
| Avior Wealth Management, LLC | 10,000 | $12,000 | 0.00% |
| AMALGAMATED BANK | 10,217 | $12,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 73,897 | $90,000 | 0.00% |